{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:34:03Z","timestamp":1791934443948,"version":"4.3.4"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Benznidazole, a 2-nitroimidazole, is the front-line treatment used against American trypanosomiasis, a parasitic infection caused by\n                    <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Trypanosoma cruzi<\/jats:named-content>\n                    . Despite nearly 40 years of use, the trypanocidal activity of this prodrug is not fully understood. It has been proposed that benznidazole activation leads to the formation of reductive metabolites that can cause a series of deleterious effects, including DNA damage and thiol depletion. Here, we show that the key step in benznidazole activation involves an NADH-dependent trypanosomal type I nitroreductase. This catalyzes an oxygen-insensitive reaction with the interaction of enzyme, reductant, and prodrug occurring through a ping-pong mechanism. Liquid chromatography\/mass spectrometry (LC\/MS) analysis of the resultant metabolites identified 4,5-dihydro-4,5-dihydroxyimidazole as the major product of a reductive pathway proceeding through hydroxylamine and hydroxy intermediates. The breakdown of this product released the reactive dialdehyde glyoxal, which, in the presence of guanosine, generated guanosine-glyoxal adducts. These experiments indicate that the reduction of benznidazole by type I nitroreductase activity leads to the formation of highly reactive metabolites and that the expression of this enzyme is key to the trypanocidal properties displayed by the prodrug.\n                  <\/jats:p>","DOI":"10.1128\/aac.05135-11","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T23:20:13Z","timestamp":1319844013000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":216,"title":["Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation"],"prefix":"10.1128","volume":"56","author":[{"given":"Belinda S.","family":"Hall","sequence":"first","affiliation":[{"name":"Queen Mary Pre-Clinical Drug Discovery Group, School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane R.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Queen Mary Pre-Clinical Drug Discovery Group, School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2005.08.009"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2010.11.010"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/605091"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"463575","DOI":"10.1155\/2009\/463575","article-title":"Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole","volume":"2009","author":"Buschini A","year":"2009","unstructured":"BuschiniA. 2009. Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole. J. Parasitol. Res. 2009:463575.","journal-title":"J. Parasitol. Res"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)","volume":"25","author":"Castro JA","year":"2006","unstructured":"CastroJA de MeccaMM BartelLC. 2006. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum. Exp. Toxicol. 25:471\u2013479.","journal-title":"Hum. Exp. Toxicol"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2174\/138945008786786082","article-title":"Glyoxalase pathway of trypanosomatid parasites: a promising chemotherapeutic target","volume":"9","author":"Chauhan SC","year":"2008","unstructured":"ChauhanSC PadmanabhanPK MadhubalaR. 2008. Glyoxalase pathway of trypanosomatid parasites: a promising chemotherapeutic target. Curr. Drug Targets 9:957\u2013965.","journal-title":"Curr. Drug Targets"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.freeradbiomed.2005.06.021","article-title":"The presence of four iron-containing superoxide dismutase isozymes in trypanosomatidae: characterization, subcellular localization, and phylogenetic origin in Trypanosoma brucei","volume":"40","author":"Dufernez F","year":"2006","unstructured":"DufernezF. 2006. The presence of four iron-containing superoxide dismutase isozymes in trypanosomatidae: characterization, subcellular localization, and phylogenetic origin in Trypanosoma brucei. Free Radic. Biol. Med. 40:210\u2013225.","journal-title":"Free Radic. Biol. Med"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.00806.x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2008.06788.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BJ20060882","article-title":"Trypanothione-dependent glyoxalase I in Trypanosoma cruzi","volume":"400","author":"Greig N","year":"2006","unstructured":"GreigN WyllieS VickersTJ FairlambAH. 2006. Trypanothione-dependent glyoxalase I in Trypanosoma cruzi. Biochem. J. 400:217\u2013223.","journal-title":"Biochem. J"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.230847"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.01213-09","article-title":"Exploiting the drug-activating properties of a novel trypanosomal nitroreductase","volume":"54","author":"Hall BS","year":"2011","unstructured":"HallBS WuX HuL WilkinsonSR. 2011. Exploiting the drug-activating properties of a novel trypanosomal nitroreductase. Antimicrob. Agents Chemother. 54:1193\u20131199.","journal-title":"Antimicrob. Agents Chemother"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0026-895X(25)10179-X","article-title":"Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase","volume":"29","author":"Heimbrook DC","year":"1986","unstructured":"HeimbrookDC SartorelliAC. 1986. Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase. Mol. Pharmacol. 29:168\u2013172.","journal-title":"Mol. Pharmacol"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2307\/3282883"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5033-5036.2005"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/tx00009a004","article-title":"Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: mechanism of reductive activation","volume":"2","author":"Kedderis GL","year":"1989","unstructured":"KedderisGL ArgenbrightLS MiwaGT. 1989. Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: mechanism of reductive activation. Chem. Res. Toxicol. 2:146\u2013149.","journal-title":"Chem. Res. Toxicol"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/j.1460-2075.1990.tb07462.x","article-title":"Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the \u2018hotspot\u2019 topogenic signal model","volume":"9","author":"Kendall G","year":"1990","unstructured":"KendallG WilderspinAF AshallF MilesMA KellyJM. 1990. Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the \u2018hotspot\u2019 topogenic signal model. EMBO J. 9:2751\u20132758.","journal-title":"EMBO J"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1371\/journal.pbio.0050211","article-title":"Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase","volume":"5","author":"Leitsch D","year":"2007","unstructured":"LeitschD KolarichD WilsonIB AltmannF DucheneM. 2007. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase. PLoS Biol. 5:e211.","journal-title":"PLoS Biol"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)44193-7"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762009000900042"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00679a013"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0006-2952(02)01663-5","article-title":"Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives","volume":"65","author":"Maya JD","year":"2003","unstructured":"MayaJD. 2003. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. Biochem. Pharmacol. 65:999\u20131006.","journal-title":"Biochem. Pharmacol"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/em.2860050512"},{"key":"e_1_3_3_25_2","first-page":"2184","article-title":"Breakage of bacterial DNA by nitrofuran derivatives","volume":"31","author":"McCalla DR","year":"1971","unstructured":"McCallaDR ReuversA KaiserC. 1971. Breakage of bacterial DNA by nitrofuran derivatives. Cancer Res. 31:2184\u20132188.","journal-title":"Cancer Res"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0003-2697(77)90597-8","article-title":"The use of Girard-T reagent in a rapid and sensitive methods for measuring glyoxal and certain other alpha-dicarbonyl compounds","volume":"81","author":"Mitchel RE","year":"1977","unstructured":"MitchelRE BirnboimHC. 1977. The use of Girard-T reagent in a rapid and sensitive methods for measuring glyoxal and certain other alpha-dicarbonyl compounds. Anal. Biochem. 81:47\u201356.","journal-title":"Anal. Biochem"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.8564199"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0003-9861(82)90383-6","article-title":"Different behaviors of benznidazole as free radical generator with mammalian and Trypanosoma cruzi microsomal preparations","volume":"218","author":"Moreno SN","year":"1982","unstructured":"MorenoSN DocampoR MasonRP LeonW StoppaniAO. 1982. Different behaviors of benznidazole as free radical generator with mammalian and Trypanosoma cruzi microsomal preparations. Arch. Biochem. Biophys. 218:585\u2013591.","journal-title":"Arch. Biochem. Biophys"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.actatropica.2008.04.011","article-title":"Differential gene expression in Trypanosoma cruzi populations susceptible and resistant to benznidazole","volume":"107","author":"Murta SM","year":"2008","unstructured":"MurtaSM. 2008. Differential gene expression in Trypanosoma cruzi populations susceptible and resistant to benznidazole. Acta Trop. 107:59\u201365.","journal-title":"Acta Trop"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.2127"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actatropica.2006.10.004","article-title":"Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole","volume":"100","author":"Nogueira FB","year":"2006","unstructured":"NogueiraFB. 2006. Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole. Acta Trop. 100:119\u2013132.","journal-title":"Acta Trop"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1111\/j.1742-4658.2009.07060.x","article-title":"Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori","volume":"276","author":"Olekhnovich IN","year":"2009","unstructured":"OlekhnovichIN GoodwinA HoffmanPS. 2009. Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori. FEBS J. 276:3354\u20133364.","journal-title":"FEBS J"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1139\/v89-331","article-title":"4,5-Dihydro-4,5-dihydroxyimidazoles as products of the reduction of 2-nitroimidazoles. HPLC assay and demonstration of equilibrium transfer of glyoxal to guanine","volume":"67","author":"Panicucci R","year":"1989","unstructured":"PanicucciR McClellandRA. 1989. 4,5-Dihydro-4,5-dihydroxyimidazoles as products of the reduction of 2-nitroimidazoles. HPLC assay and demonstration of equilibrium transfer of glyoxal to guanine. Can. J. Chem. 67:2128\u20132135.","journal-title":"Can. J. Chem"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0026-895X(25)14090-X","article-title":"The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes","volume":"17","author":"Perez-Reyes E","year":"1980","unstructured":"Perez-ReyesE KalyanaramanB MasonRP. 1980. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes. Mol. Pharmacol. 17:239\u2013244.","journal-title":"Mol. Pharmacol"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)50687-6"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01360-06"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/0006-2952(90)90086-Z","article-title":"Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules","volume":"40","author":"Raleigh JA","year":"1990","unstructured":"RaleighJA KochCJ. 1990. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmacol. 40:2457\u20132464.","journal-title":"Biochem. Pharmacol"},{"key":"e_1_3_3_38_2","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/0006-2952(86)90005-5","article-title":"Induction of DNA strand breaks by reduced nitroimidazoles. Implications for DNA base damage","volume":"35","author":"Silver AR","year":"1986","unstructured":"SilverAR McNeilSS O'NeillP JenkinsTC AhmedI. 1986. Induction of DNA strand breaks by reduced nitroimidazoles. Implications for DNA base damage. Biochem. Pharmacol. 35:3923\u20133928.","journal-title":"Biochem. Pharmacol"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00332-10"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/35016103"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33945"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(98)00127-3"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2690001"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1515\/DMDI.2008.23.1-2.125"},{"key":"e_1_3_3_45_2","first-page":"78","article-title":"Modification of guanine derivatives by reduced 2-nitroimidazoles","volume":"43","author":"Varghese AJ","year":"1983","unstructured":"VargheseAJ WhitmoreGF. 1983. Modification of guanine derivatives by reduced 2-nitroimidazoles. Cancer Res. 43:78\u201382.","journal-title":"Cancer Res"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0009-2797(85)90011-0","article-title":"Properties of 2-hydroxylaminoimidazoles and their implications for the biological effects of 2-nitroimidazoles","volume":"56","author":"Varghese AJ","year":"1985","unstructured":"VargheseAJ WhitmoreGF. 1985. Properties of 2-hydroxylaminoimidazoles and their implications for the biological effects of 2-nitroimidazoles. Chem. Biol. Interact. 56:269\u2013287.","journal-title":"Chem. Biol. Interact"},{"key":"e_1_3_3_47_2","first-page":"887","article-title":"Nitroimidazole bioreductive metabolism. Quantitation and characterisation of mouse tissue benznidazole nitroreductases in vivo and in vitro","volume":"36","author":"Walton MI","year":"1987","unstructured":"WaltonMI WorkmanP. 1987. Nitroimidazole bioreductive metabolism. Quantitation and characterisation of mouse tissue benznidazole nitroreductases in vivo and in vitro. Biochem. Pharmacol. 36:887\u2013896.","journal-title":"Biochem. Pharmacol"},{"key":"e_1_3_3_48_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1289\/ehp.8564309","article-title":"Some reactions and properties of nitro radical-anions important in biology and medicine","volume":"64","author":"Wardman P","year":"1985","unstructured":"WardmanP. 1985. Some reactions and properties of nitro radical-anions important in biology and medicine. Environ. Health Perspect. 64:309\u2013320.","journal-title":"Environ. Health Perspect"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molbiopara.2008.09.005","article-title":"Glyoxalase II does not support methylglyoxal detoxification but serves as a general trypanothione thioesterase in African trypanosomes","volume":"163","author":"Wendler A","year":"2009","unstructured":"WendlerA IrschT RabbaniN ThornalleyPJ Krauth-SiegelRL. 2009. Glyoxalase II does not support methylglyoxal detoxification but serves as a general trypanothione thioesterase in African trypanosomes. Mol. Biochem. Parasitol. 163:19\u201327.","journal-title":"Mol. Biochem. Parasitol"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(82)90105-3"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-2952(86)90565-4","article-title":"The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms","volume":"35","author":"Whitmore GF","year":"1986","unstructured":"WhitmoreGF VargheseAJ. 1986. The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms. Biochem. Pharmacol. 35:97\u2013103.","journal-title":"Biochem. Pharmacol"},{"key":"e_1_3_3_52_2","first-page":"185","article-title":"Reaction of 2-nitroimidazole metabolites with guanine and possible biological consequences","volume":"1986","author":"Whitmore GF","year":"1986","unstructured":"WhitmoreGF VargheseAJ GulyasS. 1986. Reaction of 2-nitroimidazole metabolites with guanine and possible biological consequences. IARC Sci. Publ. 1986:185\u2013196.","journal-title":"IARC Sci. Publ"},{"key":"e_1_3_3_53_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2005.06.022","article-title":"Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei","volume":"40","author":"Wilkinson SR","year":"2006","unstructured":"WilkinsonSR. 2006. Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei. Free Radic. Biol. Med. 40:198\u2013209.","journal-title":"Free Radic. Biol. Med"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711014105"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.05135-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.05135-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:54:43Z","timestamp":1741856083000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.05135-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1128\/AAC.05135-11"],"URL":"https:\/\/doi.org\/10.1128\/aac.05135-11","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14264123.15777260","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"2011-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-12-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}